How Much Does Found Weight Loss Cost?

Published on July 10, 2026 | Written by Alec Pow
This article was researched using 14 sources. See our methodology and corrections policy.

Found is a telehealth weight-care program that screens members online, connects eligible patients with clinicians, and can route prescriptions through insurance or cash-pay pharmacy channels. The realistic bill can start as a low monthly access charge when insurance supports the care path, or move into the mid-hundreds once self-pay GLP-1 medication, labs, supplies, and pharmacy rules are added.

The bill has three parts: a plan or clinical-care charge, the drug or pharmacy portion, and costs that land with insurance, labs, taxes, shipping rules, or renewal timing. Exact checkout pricing can change because Found uses plan choice, insurance review, medication selection, clinician eligibility, and pharmacy fulfillment rather than one public flat rate.

Found Health sits in the same buyer decision set as Wegovy, Zepbound, Ozempic, Mounjaro, Novo Nordisk, Eli Lilly, FDA safety language, commercial health plans, pharmacy benefit managers, local prescribers, outside labs, and retail pharmacies. That entity mix matters because the access fee is only one line. The final monthly unit can act like a subscription, a refill cycle, a copay path, or a cash-pay medication budget.

How Much Does Found Weight Loss Cost?

Jump to sections

• Entry: as of Aug. 2025, public Found offer terms list a $39 (at $30 per hour, earning that amount would take about 1.3 hours of work, before taxes) monthly PLUS insurance option, a $129 every-30-days CORE plan, a $199 every-30-days PLUS self-pay plan, a $594 six-month CORE plan, and a $199 annual PLUS insurance option shown as about $17 per month. Paying $39 for 12 months equals $468, so the annual payment is $269 lower before taxes.
• Retail-clinic comparison: CVS MinuteClinic lists a listed retail consultation at $49 and says select GLP-1 medicines may start from $149 with manufacturer coupon or as little as $25 with eligible insurance.
• Zepbound insurance signal: Lilly says eligible commercially insured patients may pay as low as commercial coverage savings of $25 for a one- or three-month supply, with government beneficiaries excluded.

Who this cost makes sense for

Found makes sense for a U.S. patient who wants weight-care access without waiting for a local obesity-medicine appointment and who is comfortable with telehealth, online forms, provider messaging, and pharmacy coordination. It can also suit someone comparing telehealth medication programs against Hers weight-loss pricing, direct manufacturer cash-pay routes, or a local clinic visit.

Makes sense if:

• You want a clinician to review eligibility for branded GLP-1, compounded GLP-1, or oral non-GLP-1 paths.
• Your insurer may cover visits or medication, but you need help with coverage checks and prior authorization.
• You want coaching and app tracking tied to the same care plan.
• You can budget separately for membership, medication, labs, copays, coinsurance, and deductibles.

Doesn’t make sense if:

• Your primary care doctor already prescribes and monitors the same medicine at a lower visit cost.
• You want a single visit instead of an auto-renewing program.
• You need in-person exams or close monitoring for complex conditions.
• Your plan excludes obesity drugs and cash-pay GLP-1 medication is outside your budget.

The main tradeoff is control. Found can put clinician review, coaching, medication screening, and follow-up messaging in one account, but the buyer still needs a clean view of the cart: access charge, prescription route, insurance status, lab responsibility, and refill schedule.

What you’re actually buying

Found is a digital weight-care program built around online intake, clinician review, medication access for eligible members, health coaching, and app-based tracking. It is different from buying a drug after a single office visit because the service centers on a care relationship that can include prescribing decisions, refill help, side-effect follow-up, insurance navigation, and plan changes over time. It also differs from a diet app because clinical eligibility and prescription management can be part of the care path.

The main substitutes are a primary care clinician, a local bariatric or obesity-medicine clinic, a retail-clinic virtual visit, and another telehealth GLP-1 platform. Found’s health-plan page describes access to providers and coaches, personalized treatment, and prescription medication access for eligible people through its care-plan description. The comparison is not only digital versus local care. It is whether the buyer wants a program that ties provider access, medication screening, coaching, and app prompts into a recurring account.

Found membership

Found’s pricing is not one flat national sticker. The public terms show plan names, monthly and longer-cycle structures, insurance-option pricing, and self-pay pricing. A buyer should treat those figures as public price signals, then read the checkout page before paying because taxes, coverage, employer access, promo eligibility, state availability, and the medication route can change the number.

Found’s general terms say subscription fees may vary by plan and promotions, taxes can be added, some plans include certain medications, and GLP-1 or compounded medication can be billed apart from the monthly fee through the subscription and medication terms. That makes the membership charge only the first line of the budget. The larger swing often comes after the provider selects a drug path and the pharmacy or insurer applies its rules. A buyer who sees a low access charge should still ask whether medical visits, medication, labs, pharmacy fulfillment, supplies, and refill timing are bundled or billed apart.

Insurance, cash pay

The medication path is the main divider. Found’s newer offer terms describe compounded GLP-1, generic oral non-GLP-1, and branded GLP-1 plans billed on a 28-day cycle, with labs excluded where applicable and branded GLP-1 medication billed separately in the 28-day plan language. That creates three budget tracks: insurance-supported branded medication, cash-pay branded medication, and a lower-drug-spend non-GLP-1 route.

Path	Main cost line	Budget risk
Insurance-supported branded GLP-1	Membership or access charge plus copay, coinsurance, or deductible	Prior authorization denial can move the buyer to cash pay
Cash-pay branded GLP-1	Found access charge plus manufacturer or pharmacy cash price	Higher doses or refill rules can move the monthly drug price
Compounded GLP-1	Plan price plus any lab or state-specific limits	Compounded drugs are not reviewed by FDA as finished products
Oral non-GLP-1	Plan charge and covered generic medication if filled through the listed channel	Lower drug spend, but the drug choice may not match buyer preference

Insurance can lower the drug line, but it can also add uncertainty through prior authorization, deductible timing, and pharmacy-benefit rules. Cash pay is easier to price at checkout, but it puts the drug line directly on the household budget.

What three Found members may pay

Insurance-supported GLP-1 case. This buyer enrolls because an insurer may cover visits or medication. The low headline number is the access charge, then the insurer controls copay, coinsurance, deductible, and prior authorization. If approval works, the monthly bill may be closer to a visit or drug copay than the cash price of Wegovy or Zepbound. If approval fails, the same buyer may face a cash-pay drug quote.

Cash-pay GLP-1 case. This buyer should plan for the Found access charge plus the drug itself. A comparable telehealth benchmark is Ro, which lists $39 (about 1.3 hours of work at $30 per hour) for the first month, ongoing membership as low as $74 per month with annual prepay, $149 monthly on a month-to-month plan, and medication charged separately through its separate medication pricing. That competitor structure shows why the drug line can outweigh the platform fee.

Non-GLP-1 or lower-drug-spend case. This buyer is open to metformin, topiramate, bupropion-naltrexone style paths, or another generic chosen by a clinician. The monthly total can be lower than brand GLP-1 cash pay, but it may be less predictable if the patient later switches medications. For readers comparing non-medication program spending, Quick Weight Loss totals show how coaching and product models can build a different monthly bill without prescription GLP-1 pricing.

Labs, pharmacy charges

The hidden-cost area is the gap between the plan price and the whole care path. Found-related add-ons can include lab work ordered by a clinician, outside pharmacy charges, brand-drug cash prices, copays, coinsurance, deductibles, sales tax, refill timing, and supplies. Hidden-cost callout: LillyDirect lists Zepbound direct self-pay range from $299 (about 1.2 full-time workdays at $30 per hour) to $449 per month, with pen needle purchase required for KwikPen and refill timing tied to program terms.

Refund timing also matters. Found’s plan language can treat medications and lab kits differently from membership fees after dispensing or shipping, and renewal timing can leave the buyer paying for a period that is no longer wanted. The FDA also warns that compounded GLP-1 drugs are not FDA-approved and reports 990 semaglutide and more than 730 tirzepatide adverse-event reports as of May 31, 2026, in its FDA compounded-drug warning.

Worked monthly total

Use this as a planning example, not a promise. Using the March 2025 promo terms that list a $74.99 monthly subscription fee after the first month and the public payment details that list Wegovy pen intro pricing from $199, the arithmetic is $74.99 plus $199 equals $273.99 before taxes, labs, supplies, denied coverage, refill changes, or pharmacy charges.

• Found access or promo membership signal: $74.99
• Introductory Wegovy pen price signal: $199
• Subtotal before outside items: $273.99
• Not included: labs, taxes, supplies, insurer cost-sharing, dose changes, or refill disruption

The same person could pay less if commercial insurance and savings rules lower the medication claim, or more if a coupon does not apply, the dose changes, or the pharmacy route changes. This is why the useful number is not the first fee alone. It is the written cart total plus the medication path chosen after clinical review.

The total after signup

The first payment is not always the long-run payment. The total can change when the clinician switches the medication, a dose changes, the insurer requests prior authorization, a deductible resets, the pharmacy cannot fill a drug, or the buyer moves from a trial or promo into a renewal period. That is why the cleanest price check is a written cart or account quote that separates membership, medication, labs, tax, and pharmacy fulfillment.

Program comparisons help frame the tradeoff. A buyer mainly seeking clinician access should compare Found against local primary care and retail-clinic visits. A buyer mainly seeking tirzepatide should compare the drug line against Zepbound cost signals before choosing a platform. A buyer mainly seeking coaching should decide whether Found’s app, provider messaging, and refill support justify a recurring account rather than a lower-touch prescription route.

Answers to Common Questions

Does Found include medication in the monthly fee?

Sometimes a plan may include certain medications when filled through a listed channel, but Found’s terms separate GLP-1, compounded medication, branded GLP-1, labs, and outside pharmacy charges in several places. Read the exact checkout terms before paying.

Can Found be covered by insurance?

Found describes insurance-supported paths, but coverage depends on plan, state, medication, visit billing, prior authorization, copay, coinsurance, and deductible. A coverage check does not guarantee that the final drug claim will be approved.

What is the cheapest public Found price signal?

The lowest public subscription signal in the cited terms is the $39 monthly PLUS insurance option, with an annual $199 option that works out near $17 per month before taxes and other charges.

Why can Found become much more expensive than the membership number?

The membership number may exclude the biggest line item. Brand GLP-1 medication, compounded medication, lab testing, supplies, taxes, or insurer cost-sharing can sit outside the access fee.

Is compounded GLP-1 the same as FDA-approved Wegovy or Zepbound?

No. FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing. A licensed clinician should decide whether any prescription path fits the patient’s health profile.